Home/Filings/4/0001209191-21-070718
4//SEC Filing

Dias Subaweerage 4

Accession 0001209191-21-070718

CIK 0001683553other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 9:08 PM ET

Size

8.2 KB

Accession

0001209191-21-070718

Insider Transaction Report

Form 4
Period: 2021-12-16
Dias Subaweerage
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-12-16+75,00075,000 total
    Exercise: $2.48Exp: 2031-12-15Common Stock (75,000 underlying)
  • Award

    Restricted Stock Units

    2021-12-16+20,00020,000 total
    Common Stock (20,000 underlying)
Footnotes (4)
  • [F1]1/48th of the shares vest on a monthly basis from December 16, 2021, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
  • [F2]Each restricted stock unit represents a contingent right to receive one share of SPRB common stock.
  • [F3]10,000 of the restricted stock units shall vest 25% on June 30, 2022, 25% shall vest on December 31, 2022 and 50% shall vest on June 30, 2023, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
  • [F4]10,000 of the restricted stock units shall vest upon the achievement of specified performance goals.

Issuer

SPRUCE BIOSCIENCES, INC.

CIK 0001683553

Entity typeother

Related Parties

1
  • filerCIK 0001825443

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 9:08 PM ET
Size
8.2 KB